Concepedia

Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degeneration

Keiko Kataoka, Kanako Itagaki, Nozumu Hashiya, Sorako Wakugawa, Koji Tanaka, Makiko Nakayama, Akiko Yamamoto, Ryo Mukai, Jyunichiro Honjyo, Ichiro Maruko,

Graefe s Archive for Clinical and Experimental Ophthalmology · 2023 · 68 citations · 19 references

DOI

Concepts

References

19

Ranibizumab for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al. · New England Journal of Medicine · 2006 · 5.9K citations · Full text

, , +12

Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

David M. Brown, Peter K. Kaiser, Mark Michels et al. · New England Journal of Medicine · 2006 · 3.5K citations

, , +13

VEGF-Trap: A VEGF blocker with potent antitumor effects

Jocelyn Holash, Sam Davis, Susan D. Croll et al. · Proceedings of the National Academy of Sciences · 2002 · 1.7K citations

, , +17

Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab

Nicholas Papadopoulos, Joel Martin, Qin Ruan et al. · Angiogenesis · 2012 · 1K citations · Full text

, , +15

HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration

Pravin U. Dugel, Adrian Koh, Yuichiro Ogura et al. · Ophthalmology · 2019 · 911 citations · Full text

, , +16